This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Pacemakers/ Defibrillators  • Cardiovascular System  • Dermatologic Disorders, Other  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Reticular telangiectatic erythema (RTE) is a new and recently described skin complication that is associated with the use of pacemakers or implantable cardioverter defibrillators.¹ To date, RTE has not been associated with the use of other devices or subcutaneously implanted metal devices; therefore, it has been suggested that RTE is exclusively associated with the use of cardiac devices.² The present report describes a case of RTE that was unrelated to the use of either pacemakers or implantable cardioverter defibrillators.

Report of a Case

In 1973, a 22-year-old man was involved in a traffic accident that required implantation of a hip prosthesis. In 1995, he was referred to the pain treatment unit of our hospital for the management of pain in the region of the hip prosthesis. In February 2000, a subarachnoid morphine reservoir was implanted (Celsite ST204; Braun Inc, Syracuse, NY). After undergoing the implantation, the patient experienced dizziness, requiring removal of the reservoir. . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION
Pedro Mercader-García, MD; Arantxa Torrijos-Aguilar, MD; Jesus de La Cuadra-Oyanguren, MD; Juan J. Vilata-Corell, MD, PhD; Jose M. Fortea-Baixauli, MD, PhD